AstraZeneca Pharma India informs about unaudited financial results

06 Feb 2018 Evaluate

AstraZeneca Pharma India has informed about the Board Meeting of the Company held on Monday, February 5, 2018, has considered and approved the Unaudited Financial Results of the Company for the quarter ended December 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8820.65 29.30 (0.33%)
25-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1763.80
Dr. Reddys Lab 1306.60
Cipla 1345.70
Zydus Lifesciences 919.40
Lupin 2292.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×